Month: October 2023

RIADE, Arábia Saudita, Oct. 31, 2023 (GLOBE NEWSWIRE) — O King Faisal Specialist Hospital and Research Centre (KFSH&RC) introduziu um serviço chamado Rapid Whole-Genome Sequencing (Rápido Sequenciamento Total de Genoma – rWGS), um desenvolvimento revolucionário, como parte da suas soluções de cuidado da saúde. Este serviço foi concebido para ajudar os médicos a diagnosticar doenças raras e genéticas, particularmente em recém-nascidos gravemente doentes que requerem uma identificação rápida e precisa da sua condição.

O serviço de Rápido Sequenciamento Total de Genoma Inteiro é inestimável para recém-nascidos com doenças raras, pois ajuda evitar o processo muitas vezes demorado de testes e tratamentos que podem se estender por meses ou até anos sem um diagnóstico preciso. O serviço aumenta as probabilidades de sobrevivência e reduz o custo geral dos cuidados de saúde, minimizando as internações hospitalares, exames desnecessários e cuidados médicos.

Notavelmente, o hospital reduziu o tempo necessário para este teste genético de uma duração típica de dois meses para menos de 35 horas. O tempo de resposta é fundamental para o planejamento dos cuidados de saúde para recém-nascidos gravemente doentes, e a entrega rápida dos resultados dos testes garante uma resposta médica rápida e personalizada, evitando atrasos que, de outra forma, poderiam levar ao agravamento da condição do paciente ou até mesmo à morte.

Como participante do Global Health Summit, onde o KFSH&RC tem um papel essencial como parceiro estratégico de cuidada da saúde, o hospital compartilha os detalhes do serviço de Rápido Sequenciamento Total de Genoma no seu estande. Os recursos de ponta do hospital incluem a análise de até 99% das sequências de DNA de amostras de sangue de pacientes, juntamente com várias soluções inovadoras de saúde.

O exame abrangente da composição genética envolve um processo simplificado de quatro etapas. Primeiro, o DNA é dividido em segmentos gerenciáveis. Em seguida, ele é codificado com um símbolo semelhante a um código de barras para facilitar a identificação, semelhante ao rastreamento de produtos em uma loja. O exame em si é realizado com equipamento especializado. Finalmente, sistemas de computador e software avançados comparam essas sequências, identificando diferenças nas sequências de DNA e identificando as mutações genéticas responsáveis pelas doenças.

O KFSH&RC fornece o mais alto nível de cuidados de saúde e proporciona a melhor experiência possível ao paciente dentro de um ambiente educacional e de pesquisa integrado. Ele colabora e compartilha sua expertise com as principais instituições locais, regionais e internacionais, e fornece serviços de classe mundial em clínica, pesquisa e educação.

Reconhecido mundialmente por seus cuidados de saúde especializados, o KFSH&RC é pioneiro em inovação médica e é um centro de pesquisa e educação médica avançada. Ele se dedica ao avanço das tecnologias médicas e à elevação do padrão de assistência médica em escala em todo o mundo, por meio de parcerias com instituições locais, regionais e internacionais nas áreas de clínica, pesquisa e educacional.

Informações de Contato:
kfshrc@mcsaatchi.com

Fotos deste comunicado podem ser encontradas em:

https://www.globenewswire.com/NewsRoom/AttachmentNg/59bc8aa4-5f6d-432a-b4e9-c26544e9aa6d

https://www.globenewswire.com/NewsRoom/AttachmentNg/76f80d26-8e56-42df-b95a-c8cdab80e449 

GlobeNewswire Distribution ID 8969319

RIYAD, Arabie saoudite, 31 oct. 2023 (GLOBE NEWSWIRE) — Dans le cadre d’un développement révolutionnaire pour le Moyen-Orient, le King Faisal Specialist Hospital and Research Centre (KFSH&RC) a introduit un service appelé séquençage rapide du génome entier (rWGS) dans le cadre de ses solutions de soins de santé. Ce service est destiné à aider les médecins à diagnostiquer les maladies rares et génétiques, en particulier chez les nouveau-nés gravement malades, nécessitant une identification rapide et précise de leur état.

Le service de séquençage rapide du génome entier est inestimable pour les nouveau-nés atteints de maladies rares, car il leur permet d’éviter le processus souvent chronophage des tests et des traitements qui peuvent s’étendre sur des mois, voire des années, sans diagnostic précis. Cela permet d’augmenter les chances de survie et de réduire le coût global des soins de santé en diminuant les admissions à l’hôpital ainsi que les examens et soins médicaux inutiles.

Fait remarquable, l’hôpital a réduit la durée nécessaire à ces examens génétiques, qui est habituellement de deux mois, à moins de 35 heures. Le temps de réponse est primordial lorsqu’il s’agit de planifier les soins de santé pour des nouveau-nés gravement malades, et la communication rapide des résultats des examens garantit une réponse médicale prompte et adaptée, évitant ainsi des retards qui pourraient entraîner une aggravation de l’état du patient, voire son décès.

Dans le cadre de sa participation au Global Health Summit, où le KFSH&RC joue un rôle essentiel en tant que partenaire stratégique dans le domaine des soins de santé, l’hôpital fournit des détails sur le service de séquençage rapide du génome entier à son stand d’exposition. Les capacités de pointe de l’hôpital comprennent l’analyse de 99 % des séquences d’ADN à partir d’échantillons sanguins de patients, ainsi que plusieurs solutions de soins de santé innovantes.

L’examen complet de la composition génétique comprend un processus rationalisé en quatre étapes. Tout d’abord, l’ADN est décomposé en segments gérables. Ensuite, il est codé avec un symbole semblable à un code-barres pour une identification facile, comme pour le suivi des produits dans un magasin. L’examen proprement dit est effectué à l’aide d’un équipement spécialisé. Enfin, des systèmes informatiques et des logiciels avancés comparent ces séquences, identifiant les différences dans les séquences d’ADN et localisant les mutations génétiques responsables des maladies.

Le KFSH&RC offre le plus haut niveau de soins de santé et la meilleure expérience possible aux patients dans un environnement intégré d’enseignement et de recherche. Il collabore et partage son expertise avec des institutions locales, régionales et internationales de premier plan afin de fournir un service compétitif au niveau mondial dans les domaines clinique, de la recherche et de l’enseignement.

Reconnu mondialement pour ses soins de santé spécialisés, le KFSH&RC constitue un pionnier de l’innovation médicale et une plaque tournante de la recherche et de l’enseignement médical de pointe. Il s’engage à faire progresser les technologies médicales et à élever le niveau des soins de santé dans le monde entier grâce à des partenariats avec des institutions locales, régionales et internationales de premier plan dans les domaines clinique, de la recherche et de l’enseignement.

Coordonnées :
kfshrc@mcsaatchi.com

Les photos jointes au présent communiqué sont disponibles aux adresses suivantes :

https://www.globenewswire.com/NewsRoom/AttachmentNg/59bc8aa4-5f6d-432a-b4e9-c26544e9aa6d

https://www.globenewswire.com/NewsRoom/AttachmentNg/76f80d26-8e56-42df-b95a-c8cdab80e449

GlobeNewswire Distribution ID 8969319

Tempo de espera no leito reduzido de 32 horas para 6 horas

RIADE, Arábia Saudita, Oct. 31, 2023 (GLOBE NEWSWIRE) — Os profissionais de saúde estão enfrentando um aumento contínuo na demanda por serviços de saúde, exigindo um redirecionamento dos esforços para melhorar a eficiência operacional das instituições de saúde. Em resposta a este desafio que os prestadores de cuidados de saúde em todo o mundo enfrentam, o Capacity Command Center no King Faisal Specialist Hospital and Research Centre (KFSH&RC) emergiu como pioneiro no aumento da eficiência operacional através da implementação de procedimentos reconhecidos mundialmente. Essencialmente, visa melhorar os resultados gerais da saúde em alinhamento com as metas da Saudi Vision 2030 (Visão Saudita).

Desde o seu lançamento em setembro de 2021, o Centro realizou mais de 170.000 procedimentos de intervenção, reduzindo significativamente o tempo de espera no leito de 32 horas para 6 horas. O departamento de emergência também teve uma redução de 14% no tempo de espera. Além disso, o tempo de espera na farmácia e no laboratório melhoraram, com mais de 90% dos beneficiários sendo atendidos em menos de 15 minutos.

Desde a sua criação, o Centro tornou-se a principal fonte de tomada de decisão baseada em dados. Ele continua a monitorar continuamente os movimentos dos pacientes para manter a qualidade do atendimento, aderir aos procedimentos operacionais padrão e prever os volumes de demanda para mitigar riscos e enfrentar possíveis desafios.

Como parceiro estratégico de saúde na Global Health Exhibition em Riade de 29 a 31 de outubro, o KFSH&RC está apresentando os seus mecanismos para aprimoramento da eficiência operacional, dos resultados de saúde e da experiência do paciente, posicionando-se como uma solução de saúde líder na região.

O Capacity Command Center conta com uma estratégia que ajusta planos de negócios e intervenções com base em práticas baseadas em evidências impulsionadas pela inteligência artificial para aprimorar o mapeamento e o planejamento do fluxo de trabalho. Os serviços do Centro incluem relatórios técnicos, mineração de dados, aprimoramento do desempenho operacional e análise de processos e planos, culminando na emissão regular de relatórios.

Este Centro faz parte dos esforços contínuos do KFSH&RC de aproveitar todos os recursos e oferecer as tecnologias mais recentes para aprimorar os resultados e a eficiência operacional. Seu objetivo é ser a opção ideal para todos os pacientes que busquem serviços de saúde especializados, tornando esses serviços acessíveis a uma gama mais ampla de beneficiários.

O KFSH&RC é reconhecido mundialmente por seus serviços de saúde especializados e é pioneiro em inovação, pesquisa médica avançada e educação médica. A instituição também trabalha no desenvolvimento tecnologias médicas e aprimoramento dos padrões de cuidados de saúde em todo o mundo em parceria com as principais instituições locais, regionais e internacionais, para oferecer um serviço de classe mundial nos campos clínico, de pesquisa e educacional.

Informações de Contato:
kfshrc@mcsaatchi.com

Fotos deste comunicados disponíveis em

https://www.globenewswire.com/NewsRoom/AttachmentNg/fe240c06-779b-48f8-bf90-542602be547f

https://www.globenewswire.com/NewsRoom/AttachmentNg/879c9435-ea23-47f2-b81a-240a1e2bb3a5

GlobeNewswire Distribution ID 8969263

Réduction du temps d’attente pour un lit d’hospitalisation de 32 à 6 heures

RIYAD, Arabie saoudite, 31 oct. 2023 (GLOBE NEWSWIRE) — Les prestataires de soins de santé doivent répondre à une demande en services de santé toujours plus forte, qui les conduit à recentrer leurs efforts sur l’optimisation opérationnelle des établissements de soins. Le Capacity Command Center du King Faisal Specialist Hospital and Research Centre (KFSH&RC) s’inscrit à l’avant-garde des démarches d’amélioration spécifiques en matière d’efficacité opérationnelle via la mise en place de procédures internationalement reconnues pour répondre aux enjeux des prestataires de santé du monde entier. L’hôpital vise essentiellement à relever le niveau sanitaire global en s’alignant sur les objectifs du plan de développement Saudi Vision 2030.

Depuis sa création en septembre 2021, le centre a réalisé plus de 170 000 interventions, et a considérablement abrégé le temps d’attente pour un lit d’hospitalisation, le faisant passer de 32 à 6 heures. Le service des urgences a également enregistré des temps d’attente moins longs de 14 %. En outre, les temps d’attente à la pharmacie ou au laboratoire se sont écourtés. Plus de 90 % des patients reçoivent désormais leurs soins en moins de 15 minutes.

Le centre constitue la source principale des prises de décision axées sur les données depuis son origine. L’activité des patients fait notamment l’objet d’une veille permanente visant le maintien qualitatif des soins. Par ailleurs, le centre respecte des procédures opérationnelles normalisées et anticipe la demande en soins pour limiter le risque, tout en s’attachant à remédier à d’éventuels défis.

En parallèle, au titre de partenaire santé stratégique de la Global Health Exhibition organisée à Riyad du 29 au 31 octobre, le KFSH&RC présente ses solutions d’amélioration en matière d’efficacité opérationnelle, les résultats de ses prestations et du vécu des patients, se positionnant ainsi comme le leader régional des soins de santé.

La stratégie du Capacity Command Center s’appuie sur l’ajustement des plans d’activité et des interventions à des pratiques factuelles pilotées par l’intelligence artificielle pour mieux cartographier et planifier les flux de travail. Les services du centre comprennent l’établissement de rapports techniques, la recherche de données, l’optimisation des performances opérationnelles, mais aussi la conception de processus et de plans d’examen menant à la publication régulière de rapports.

Ce centre illustre bien les efforts constants déployés par le KFSH&RC pour exploiter toutes les ressources et développer les dernières technologies pour améliorer à la fois les résultats et l’efficacité opérationnelle. Son but et de devenir le choix idéal de tout patient en quête de soins de santé spécialisés, et de rendre les soins accessibles à une plus grande population de patients.

Mondialement reconnu pour ses prestations de santé spécialisées, le KFSH&RC est un modèle d’innovation, mais aussi de recherche et d’éducation médicale avancées. L’hôpital s’efforce de développer des technologies médicales et d’améliorer le niveau des soins de santé dans le monde entier, et collabore avec des organisations locales, régionales et internationales de premier plan pour atteindre les meilleures pratiques dans les domaines cliniques, de recherche et d’éducation.

Coordonnées :
kfshrc@mcsaatchi.com

Les photos jointes au présent communiqué sont disponibles aux adresses suivantes : https://www.globenewswire.com/NewsRoom/AttachmentNg/fe240c06-779b-48f8-bf90-542602be547f

https://www.globenewswire.com/NewsRoom/AttachmentNg/879c9435-ea23-47f2-b81a-240a1e2bb3a5

GlobeNewswire Distribution ID 8969263

RIYADH, Saudi Arabia, Oct. 31, 2023 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH&RC) has achieved a significant milestone by successfully conducting liquid biopsies on patients spanning various age groups. This innovative approach offers a safer alternative to conventional tissue biopsies. Notably, KFSH&RC stands out as the first healthcare facility in the Middle East to adopt this cutting-edge technology.

This groundbreaking method is distinguished by its ability to detect approximately 50 genes associated with cancer and over 3,000 genetic mutations. This represents a pivotal advancement in patient care, eliminating the need to extract tissue from the affected area for examination. This transformative step greatly enhances healthcare outcomes and elevates the overall patient experience.

Liquid biopsy offers advantages over traditional tissue biopsies. It’s less invasive, involving a simple 10 ml blood sample that can be repeated during treatment. Additionally, it provides high accuracy in swiftly detecting tumor biomarkers, predicting treatment responses, identifying emerging mutations, and confirming the absence of tumor recurrence, marking a significant advancement in cancer science.

This technology presents a safer alternative to traditional biopsies for patients facing challenges in accessing affected tissue without surgical intervention, as seen in cases like lung cancer. It is particularly beneficial for elderly patients, for whom a lung tissue biopsy may not be suitable due to the potential for severe complications associated with it.

King Faisal Specialist Hospital and Research Centre Utilizes Early Cancer Detection Technology for 50 Genes_02King Faisal Specialist Hospital and Research Centre Utilizes Early Cancer Detection Technology for 50 Genes_02

As a strategic health partner at the Global Health Exhibition in Riyadh from October 29 to 31, KFSH&RC will showcase its pavilion in the accompanying exhibition, where visitors can explore Liquid biopsy technology and various other healthcare solutions and technologies.

Liquid biopsy technology holds promise for other stages of cancer treatment at KFSH&RC. Through the routine use of the test, it is possible to build a database of tumor-causing mutations in the local community, which helps in early diagnosis of cancer before tumors form, in addition to tracking changes in the patient’s condition, frequently during treatment, allowing timely adjustments to treatment plans and preventing worsening of the condition.

This achievement is a part of KFSH&RC’s ongoing commitment to harness advanced technologies for enhancing operational excellence and patient care. The test facilitates swift clinical decision-making for cancer patient management and reduces both the testing time and its process through full automation.

KFSH&RC stands as one of the world’s prominent institutions in delivering specialized healthcare, leading the way in innovation, and serving as an advanced hub for medical research and education. Furthermore, it actively endeavors to advance medical technologies and elevate global healthcare standards through collaborations with significant local, regional, and international organizations, aiming to deliver world-class clinical, research, and educational services.

Contact information:
kfshrc@mcsaatchi.com

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/3ba7a2cd-ae09-4d9a-8658-a5efc2b198c3

https://www.globenewswire.com/NewsRoom/AttachmentNg/9de0dc61-7dc5-47e4-af70-09088ad689e1

GlobeNewswire Distribution ID 8969156

LONDON, Oct. 31, 2023 (GLOBE NEWSWIRE) — More than 400 delegates from over 35 countries are expected to attend the 17th annual Global Residence and Citizenship Conference, which takes place next week (8-10 November) at the Shangri-La Hotel DIFC in Dubai, UAE.

Hosted by world-leading international citizenship and residence advisory firm Henley & Partners, this annual event has become the world’s largest and most significant conference on private wealth and investment migration, bringing together presidents, prime ministers, senior government ministers and officials, leading academics, private client advisors, wealth management professionals, and top-tier financial and business media.

The 2023 conference program features sophisticated, cutting-edge content on the major developments shaping investment migration and geopolitics today, offering delegates the opportunity to engage with the world’s leading minds and latest ideas around the central themes of global citizenship and interconnectivity.

Dr. Christian H. Kalin, Group Chairman of Henley & Partners, who will also be speaking at the conference, points out that there could not be a more relevant and necessary time to connect across borders as citizens of the world. “At a moment in our history when our world seems increasingly fractured and polarized, it is more important than ever for us to focus our minds on our shared humanity and how we can be stronger together. While it may mean different things to different people, global citizenship is based on the principle that we all have responsibilities to the world as a whole, rather than just our own local communities or countries. This conference aims to expand our horizons through global learning and understanding so that we can effect change in a more meaningful sense on both a small and larger scale.”

Notable key speakers at the conference include the Prime Ministers of Montenegro, H.E. Dr. Dritan Abazovic, and of Grenada, the Hon. Dickon Mitchell, as well as the former President and Speaker of the Parliament of the Maldives, the Hon. Mohamed Nasheed. CEO of the Dubai Economic Development Corporation, Hadi Badri, along with Prof. Dr. Christian Joppke of the Institute of Sociology at the University of Bern in Switzerland, Dr. Titus Gebel, President of the Free Cities Foundation in Germany, Prof. Dr. Khalid Koser, Executive Director of the Global Community Engagement and Resilience Fund, Chief Partnership Officer of Women in AI, Middle East, Debbie Botha, and Dr. Parag Khanna, Founder and CEO of Climate Alpha in Singapore, among many others. They all will share their perspectives on the key social, economic, political and environmental trends shaping our world.

Another highlight of the conference will be the 2023 Global Citizen Award Dinner on 9 November to honor a remarkable individual working to advance one of the global challenges affecting humanity today. Hosted in collaboration with the Swiss non-profit humanitarian organization Andan Foundation, this year’s laureate will be announced at the gala event and the net proceeds of the evening will be donated to the foundation which focuses on self-reliance of refugees through education, entrepreneurship, and employment.

Notes to Editors

For further information and media accreditation to attend the 17th annual Global Residence and Citizenship Conference, please contact:

Sarah Nicklin
Group Head of Public Relations
sarah.nicklin@henleyglobal.com
Mobile: +27 72 464 8965

About Henley & Partners

Henley & Partners is the global leader in residence and citizenship by investment. Each year, hundreds of wealthy individuals and their advisors rely on our expertise and experience in this area. The firm’s highly qualified professionals work together as one team in over 40 offices worldwide.

The concept of residence and citizenship by investment was created by Henley & Partners in the 1990s. As globalization has expanded, residence and citizenship have become topics of significant interest among the increasing number of internationally mobile entrepreneurs and investors whom we proudly serve every day.

Henley & Partners also runs the world’s leading government advisory practice for investment migration, which has raised more than USD 12 billion in foreign direct investment. Trusted by governments, the firm has been involved in strategic consulting and in the design, set-up, and operation of the world’s most successful residence and citizenship programs.
https://www.henleyglobal.com

GlobeNewswire Distribution ID 1000896628